Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation

Author's Avatar
May 15, 2023

Gilead Sciences, Inc. (Nasdaq:GILD) and Arcus Biosciences, Inc. (NYSE:RCUS, Financial) today announced that the companies have expanded the previously+announced research collaboration focused on oncology to include therapies for the treatment of inflammatory diseases. The expanded collaboration builds upon Gilead’s growing presence in inflammatory disease and serves as a step towards broadening Arcus’ capabilities and portfolio beyond oncology and into inflammation.